Schizophrenia News and Research

Latest Schizophrenia News and Research

Baucus: 'effectiveness' part of health-care bill, could reduce health xosts

"Senate Finance Chairman Max Baucus, D-Mont., said Tuesday he expects Senate health-care legislation will include provisions encouraging doctors to compare drugs and therapies for their effectiveness," Dow Jones Newswires reports.

10 Jun 2009

Novel approach for treating cognitive impairments

Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.

9 Jun 2009

Having flu when pregnant increases risk of schizophrenia in offspring

When mothers become infected with influenza during their pregnancy, it may increase the risk for schizophrenia in their offspring. Influenza is a very common virus and so there has been substantial concern about this association. A new study in the June 15th issue of Biological Psychiatry, published by Elsevier suggests that the observed association depends upon a pre-existing vulnerability in the fetus.

9 Jun 2009

Skin cells provide new knowledge about brain functions

Until now diseases like schizophrenia and bipolar disorder have been difficult to study biologically, since this would entail taking samples from the patient's brain.

3 Jun 2009

Research sheds new light on how the brain processes what the eye sees

Researchers at the Center for Molecular and Behavioral Neuroscience (CMBN) at Rutgers University in Newark have identified the need to develop a new framework for understanding "perceptual stability" and how we see the world with their discovery that visual input obtained during eye movements is being processed by the brain but blocked from awareness.

2 Jun 2009

Schering-Plough announces European filing of Sycrest (asenapine) for schizophrenia and bipolar I disorder

Schering-Plough Corporation has announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for Sycrest (asenapine) sublingual tablets for the treatment of schizophrenia and manic episodes associated with bipolar I disorder. The application will follow the Centralized Procedure.

2 Jun 2009

Low birth weight linked to psychosis-like symptoms

Low birth weight babies are at greater risk of developing psychosis-like symptoms as they grow up, research suggests. The study, published in the June issue of the British Journal of Psychiatry, shows a link between children's size at birth and their mental health at the age of 12.

28 May 2009

Neuroscientists reach consensus on how the brain processes speech and language

Neuroscientists feel they are much closer to an accepted unified theory about how the brain processes speech and language, according to a scientist at Georgetown University Medical Center who first laid the concepts a decade ago and who has now published a review article confirming the theory.

26 May 2009

Canadian men reluctant to consult mental health services

Between 20 and 70 percent of Canadians affected by mental illness shun medical treatment. Such avoidance of services provided by doctors and psychologists is particularly acute among men, according to a recent study published in the Journal of Behavioral Health Services & Research.

22 May 2009

Novel method stimulates growth of new neurons in adult brain

University at Buffalo researchers have identified a new mechanism that plays a central role in adult brain stem cell development and prompts brain stem cells to differentiate into neurons.

21 May 2009

Schizophrenia, substance abuse, and violent crime

In the debate surrounding violent crimes referred to as "acts of madness" or the like, it is often assumed that the violence is a direct result of the perpetrator's mental illness.

20 May 2009

Nanoparticles used to stimulate growth of new neurons in adult brain

University at Buffalo researchers have identified a new mechanism that plays a central role in adult brain stem cell development and prompts brain stem cells to differentiate into neurons.

20 May 2009

Discovery of proteins underlying devastating brain diseases

Scientists at the Wellcome Trust Sanger Institute have discovered a set of brain proteins responsible for some of the most common and devastating brain diseases.

19 May 2009

'Singing brains' offers hope for better treatments for epilepsy and schizophrenia

Studying the way a person's brain 'sings' could improve our understanding of conditions such as epilepsy and schizophrenia and help develop better treatments, scientists at Cardiff University have discovered.

19 May 2009

Protein neuregulin 1 critical to insulating the body's wiring could also become treatment target

A new protein identified as critical to insulating the wiring that connects the brain and body could one day be a treatment target for divergent diseases, from rare ones that lower the pain threshold to cancer, Medical College of Georgia researchers say.

19 May 2009

Cognition already seriously impaired in first episode of schizophrenia

Significant and widespread cognitive problems appear to exist in schizophrenia in its earliest phase, making it very hard for people with the disorder to work, study or be social, according to a new study published by the American Psychological Association.

13 May 2009

FDA approve Fanapt tablets (iloperidone) to treat adults with schizophrenia

The U.S. Food and Drug Administration has approved Fanapt tablets (iloperidone) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder.

7 May 2009

Potential molecular target for new schizophrenia treatments

A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.

5 May 2009

Scientists learn to induce gamma oscillations in the brain

Scientists have studied high-frequency brain waves, known as gamma oscillations, for more than 50 years, believing them crucial to consciousness, attention, learning and memory.

26 Apr 2009

Brain works best when cells keep right rhythms

It is said that each of us marches to the beat of a different drum, but new Stanford University research suggests that brain cells need to follow specific rhythms that must be kept for proper brain functioning.

26 Apr 2009